Skip to content

Clinical trials

Completed Bipolar Disorder trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Status: Completed Country / region: Russia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20048
20056
20063
20095
20112
20121
20131
20141
20161
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.6
AstraZeneca4
Eli Lilly and Company4
Intra-Cellular Therapies, Inc.3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Novartis Pharmaceuticals2
Forest Laboratories1
Janssen Pharmaceutica N.V., Belgium1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder30
Mania5
Schizophrenia4
Affective Disorders, Psychotic1
Autistic Disorder1
Major Depressive Disorder1
Mood Disorders1
Psychotic Disorders1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.